摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-乙酰-4’-甲氧基联苯醚 | 54916-28-8

中文名称
4-乙酰-4’-甲氧基联苯醚
中文别名
4'-(4-甲氧基苯氧基)乙酰苯;4-乙酰-4-甲氧基联苯醚;1-ó4-(4-甲氧基苯氧基)苯基乙基-1-酮
英文名称
1-[4-(4-methoxyphenoxy)phenyl]ethanone
英文别名
1-[4-(4-Methoxy-phenoxy)-phenyl]-ethanone;1-(4-(4-methoxyphenoxy)phenyl)ethan-1-one;1-[4-(4-methoxyphenoxy)phenyl]-ethanone;1-(4-(4-methoxyphenoxy)phenyl)ethanone;4-methoxyphenyl 4-acetylphenyl ether;1-[4-(4-Methoxyphenoxy)phenyl]ethan-1-one
4-乙酰-4’-甲氧基联苯醚化学式
CAS
54916-28-8
化学式
C15H14O3
mdl
MFCD00052928
分子量
242.274
InChiKey
ICXPZMQQZWKKMN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    56-58°C
  • 沸点:
    198-201°C 2mm
  • 密度:
    1.123±0.06 g/cm3(Predicted)
  • 闪点:
    198-201°C/2mm

计算性质

  • 辛醇/水分配系数(LogP):
    3.3
  • 重原子数:
    18
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.133
  • 拓扑面积:
    35.5
  • 氢给体数:
    0
  • 氢受体数:
    3

安全信息

  • 危险品标志:
    Xi
  • 安全说明:
    S22,S24/25
  • 海关编码:
    2914509090
  • 危险性防范说明:
    P261,P280,P301+P312,P302+P352,P305+P351+P338
  • 危险性描述:
    H302,H315,H319,H335
  • 储存条件:
    室温

SDS

SDS:5b54867b0f480a9364faf89eb7d4e14f
查看
Name: 1-[4-(4-Methoxyphenoxy)phenyl]ethan-1-on 97% Material Safety Data Sheet
Synonym: 4-Acetyl-4-methoxydiphenyl ethe
CAS: 54916-28-8
Section 1 - Chemical Product MSDS Name:1-[4-(4-Methoxyphenoxy)phenyl]ethan-1-on 97% Material Safety Data Sheet
Synonym:4-Acetyl-4-methoxydiphenyl ethe

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
54916-28-8 1-[4-(4-Methoxyphenoxy)phenyl]ethan-1- 97% unlisted
Hazard Symbols: None Listed.
Risk Phrases: None Listed.

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Not available.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause irritation of the digestive tract. May be harmful if swallowed.
Inhalation:
May cause respiratory tract irritation. May be harmful if inhaled.
Chronic:
Not available.

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately.
Notes to Physician:
Treat symptomatically and supportively.

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 54916-28-8: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: off-white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 52 - 55 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C15H14O3
Molecular Weight: 242

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 54916-28-8 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
1-[4-(4-Methoxyphenoxy)phenyl]ethan-1-one - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
No information available.
IMO
No information available.
RID/ADR
No information available.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 54916-28-8: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 54916-28-8 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 54916-28-8 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    PTP1B选择性抑制剂不带电荷的儿茶酚衍生物的设计,合成和生物学评估
    摘要:
    蛋白质酪氨酸磷酸酶1B(PTP1B)是有效治疗T2DM和肥胖症的有希望且经过验证的治疗靶标。但是,带电的PTP1B抑制剂由于其低的细胞渗透性和较差的生物利用度而受到限制。基于活性天然产物,通过靶向磷酸二芳基酯结合位点和催化位点,鉴定了两个系列的不带电荷的邻苯二酚衍生物为PTP1B抑制剂。最有效的抑制剂22对PTP1B的IC 50为0.487μM,相对于TCPTP具有很强的选择性(27倍)。还进行了动力学研究,发现22种可作为竞争性PTP1B抑制剂。22例C2C12肌管的治疗显着增加了IRβ,Akt和IRS1的磷酸化水平。其作用谱与胰岛素产生的相似,表明其作为一种新的非胰岛素依赖性候选药物的潜力。
    DOI:
    10.1016/j.ejmech.2017.05.007
  • 作为产物:
    描述:
    4-溴苯甲醚N1,N2-双(2-噻吩甲基)-乙二酰胺caesium carbonatesodium ascorbatecopper(l) chloride 、 copper(I) bromide 、 sodium hydroxide 作用下, 以 1,4-二氧六环二甲基亚砜 为溶剂, 反应 20.0h, 生成 4-乙酰-4’-甲氧基联苯醚
    参考文献:
    名称:
    从药物化合物库中鉴定铜催化的C-O偶联的草酰胺配体
    摘要:
    一个典型的药物化合物库具有分子多样性,可以为发现新的配体结构提供平台。本文中,我们描述了这种方法与高通量筛选的结合使用,以鉴定N,N'-双(噻吩-2-基甲基)草酰胺为配体,通常对铜催化的C-O交叉偶联有效。在温和的条件下都可以同时使用联芳醚和苯酚。
    DOI:
    10.1002/cctc.201900393
点击查看最新优质反应信息

文献信息

  • Synthesis of copper nanoparticles supported on a microporous covalent triazine polymer: an efficient and reusable catalyst for O-arylation reaction
    作者:Pillaiyar Puthiaraj、Wha-Seung Ahn
    DOI:10.1039/c5cy01590a
    日期:——

    Cu NPs immobilized on a microporous covalent triazine polymer obtained by a cost-effective synthesis method were evaluated as a catalyst for Ullmann coupling of O-arylation.

    通过一种成本效益高的合成方法获得的微孔共价三嗪聚合物上固定的Cu NPs被评估为Ullmann偶联的催化剂-芳香化。

  • Copper promoted synthesis of diaryl ethers
    作者:Rajshekhar Ghosh、Ashoka G. Samuelson
    DOI:10.1039/b401179a
    日期:——
    An efficient protocol using copper based reagents for the coupling of aryl halides with phenols to generate diaryl ethers is described. A copper(I) complex, [Cu(CH3CN)4]ClO4, or the readily available copper(II) source, CuCO3·Cu(OH)2·H2O (in combination with potassium phosphate), can be used. Aryl halides and phenols with different steric and electronic demands have been used to assess the efficiency of the procedure. The latter source of copper gives better yields under all conditions.
    文中描述了一种利用基于铜的试剂实现芳基卤与酚偶联生成二芳基醚的高效协议。可以使用铜(I)配合物,例如[Cu(CH3CN)4]ClO4,或者易于获得的铜(II)源,即铜碳酸盐·氢氧化铜·水(结合磷酸钾)。根据不同的立体和电子需求,使用不同类型的芳基卤和酚来评估该过程的效率。在所有条件下,后一种铜源能够提供更好的产率。
  • Facile aromatic nucleophilic substitution (S<sub>N</sub>Ar) reactions in ionic liquids: an electrophile–nucleophile dual activation by [Omim]Br for the reaction
    作者:Xiao Zhang、Guo-ping Lu、Chun Cai
    DOI:10.1039/c6gc01742h
    日期:——
    A facile aromatic nucleophilic substitution reaction (SNAr) in recyclable [Omim]Br under relatively mild conditions has been described. An electrophile-nucleophile dual activation by [Omim]Br is also discovered based on control experiments,...
    已经描述了在相对温和的条件下在可再循环的[Omim] Br中的容易的芳族亲核取代反应(SNAr)。基于对照实验,还发现了[Omim] Br引起的亲电亲核双重激活,...
  • Efficient Iron/Copper-Cocatalyzed O-Arylation of Phenols with Bromoarenes
    作者:Songlin Zhang、Xiaoyan Liu
    DOI:10.1055/s-0030-1259291
    日期:2011.1
    Low catalytic amount CuI and Fe(acac)3 were found to effectively promote the C-O cross-coupling reaction in the presence of K2CO3 as the base. A serious of diaryl ethers with different substitutents can be synthesized in good to excellent yields. This efficient and economic method is attractive for applications on an industrial scale.
    研究发现,在碳酸钾作为碱的条件下,低催化量的碘化铜和三(乙酰丙酮)铁能有效促进C-O交叉偶联反应。一系列含有不同取代基的二芳基醚可被合成,产率从良好到优异不等。这种高效且经济的方法在工业规模的应用上颇具吸引力。
  • Compounds, their preparation and use
    申请人:Novo Nordisk A/S
    公开号:US06555577B1
    公开(公告)日:2003-04-29
    The present invention relates to compounds of the general formula (I) The compounds are useful in the treatment and/or prevention of conditions mediated by nuclear receptors, in particular the Peroxisome Proliferator-Activated Receptors (PPAR).
    本发明涉及一般式(I)的化合物。 这些化合物在治疗和/或预防由核受体介导的疾病中具有用途,特别是过氧化物酶体增殖激活受体(PPAR)。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐